Concepedia

Luping Zhao

LZ

Statistics

Publications

22

Citations

1.4K

H-Index

18

Active since

2009

Affiliations

Eli Lilly (United States)(Current)

University of Southern California

Texas Children's Hospital

Chungbuk National University Hospital

Centre Hospitalier Régional Universitaire de Brest

Luping Zhao is an author at Eli Lilly (United States) specializing in medicine, oncology, and combination chemotherapy.

Publications per year

2009–2024

22

Publications

22

Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer

Naiyer A. Rizvi, Byoung Chul Cho, Niels Reinmuth et al. · JAMA Oncology · 2020 · 628 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Piezo1-Regulated Mechanotransduction Controls Flow-Activated Lymphatic Expansion

Dongwon Choi, Eunkyung Park, Roy P. Yu et al. · Circulation Research · 2022 · 101 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC

Naiyer A. Rizvi, B. Chul Cho, Niels Reinmuth et al. · Annals of Oncology · 2018 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Bayesian Semiparametric Temporally-Stratified Proportional Hazards Model with Spatial Frailties

Timothy Hanson, Alejandro Jara, Luping Zhao · Bayesian Analysis · 2012 · 53 citations · Full text

Public Health, Biostatistics, Oncology +17

Piezo1 regulates meningeal lymphatic vessel drainage and alleviates excessive CSF accumulation

Dongwon Choi, Eun-Kyung Park, Joshua Choi et al. · Nature Neuroscience · 2024 · 52 citations · Full text

Medicine, Neurobiology, Neuroscience +17

1–5 of 22